Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3377)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$530.49
Total Value
$63.66K
Shares Held After
8,710
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$530.03
Total Value
$424.02K
Shares Held After
8,830
% of Holdings
8.3%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
11,894
Price
$13.05
Total Value
$155.19K
Shares Held After
198,588
% of Holdings
5.7%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
964
Price
$9.21
Total Value
$8.88K
Shares Held After
22,389
% of Holdings
4.1%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
963
Price
$8.93
Total Value
$8.60K
Shares Held After
23,353
% of Holdings
4.0%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
2,771
Price
$60.11
Total Value
$166.56K
Shares Held After
4,729
% of Holdings
36.9%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
11,269
Price
$60.11
Total Value
$677.36K
Shares Held After
14,731
% of Holdings
43.3%
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
2,607
Price
$60.11
Total Value
$156.70K
Shares Held After
4,893
% of Holdings
34.8%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$15.30
Total Value
$7.65K
Shares Held After
20,406
% of Holdings
2.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$15.57
Total Value
$7.78K
Shares Held After
20,906
% of Holdings
2.3%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
300
Price
$15.28
Total Value
$4.58K
Shares Held After
21,406
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
4,968
Price
$59.16
Total Value
$293.91K
Shares Held After
166,818
% of Holdings
2.9%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
2,427
Price
$58.32
Total Value
$141.53K
Shares Held After
171,786
% of Holdings
1.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Caudill Cortney — SVP, CHIEF OPERATING OFFICER
Shares
8,857
Price
$67.64
Total Value
$599.09K
Shares Held After
7,055
% of Holdings
55.7%
MANNKIND CORP (MNKD)
Castagna Michael — Director
Shares
100,000
Price
$2.59
Total Value
$259.00K
Shares Held After
2,575,911
% of Holdings
3.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,460
Price
$14.68
Total Value
$285.67K
Shares Held After
643,471
% of Holdings
2.9%
Viking Therapeutics, Inc. (VKTX)
Aubuchon Neil William — Chief Commercial Officer
Shares
4,475
Price
$33.50
Total Value
$149.91K
Shares Held After
4,475
% of Holdings
100.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
3,508
Price
$22.67
Total Value
$79.53K
Shares Held After
66,820
% of Holdings
5.0%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
1,000
Price
$6.60
Total Value
$6.60K
Shares Held After
628,813
% of Holdings
0.2%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$10.06
Total Value
$178.23K
Shares Held After
231,584
% of Holdings
7.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
177,690
Price
$17.72
Total Value
$3.15M
Shares Held After
5,285,156
% of Holdings
3.3%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
1,684
Price
$75.58
Total Value
$127.28K
Shares Held After
242,662
% of Holdings
0.7%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
117,604
Price
$75.26
Total Value
$8.85M
Shares Held After
244,346
% of Holdings
32.5%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
7,382
Price
$74.11
Total Value
$547.09K
Shares Held After
361,950
% of Holdings
2.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Khan Najat — Director
Shares
28,298
Price
$3.35
Total Value
$94.66K
Shares Held After
2,262,085
% of Holdings
1.2%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
36,766
Price
$19.17
Total Value
$704.66K
Shares Held After
339,392
% of Holdings
9.8%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
5,089
Price
$13.00
Total Value
$66.16K
Shares Held After
132,898
% of Holdings
3.7%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
29,871
Price
$30.02
Total Value
$896.81K
Shares Held After
25,000
% of Holdings
54.4%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
80,000
Price
$35.32
Total Value
$2.83M
Shares Held After
188,954
% of Holdings
29.7%
IONIS PHARMACEUTICALS INC (IONS)
O'NEIL PATRICK R. — EVP CLO & General Counsel
Shares
10,148
Price
$75.25
Total Value
$763.66K
Shares Held After
62,211
% of Holdings
14.0%
Kiniksa Pharmaceuticals International, plc (KNSA)
Ragosa Mark — CHIEF FINANCIAL OFFICER
Shares
18,741
Price
$46.24
Total Value
$866.58K
Shares Held After
12,086
% of Holdings
60.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Ragosa Mark — CHIEF FINANCIAL OFFICER
Shares
17,981
Price
$45.58
Total Value
$819.57K
Shares Held After
30,827
% of Holdings
36.8%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
3,116
Price
$13.02
Total Value
$40.58K
Shares Held After
210,482
% of Holdings
1.5%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
247
Price
$2.54
Total Value
$626.39
Shares Held After
514,304
% of Holdings
0.0%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
2,000
Price
$11.21
Total Value
$22.42K
Shares Held After
7,450
% of Holdings
26.8%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
181,219
Price
$2.00
Total Value
$362.44K
Shares Held After
62,586
% of Holdings
74.3%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
65,000
Price
$62.06
Total Value
$4.03M
Shares Held After
6,000
% of Holdings
91.5%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
61,652
Price
$60.08
Total Value
$3.70M
Shares Held After
6,000
% of Holdings
91.1%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
43,348
Price
$59.26
Total Value
$2.57M
Shares Held After
72,652
% of Holdings
37.4%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
2,449
Price
$61.26
Total Value
$150.03K
Shares Held After
6,000
% of Holdings
29.0%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
10,072
Price
$60.47
Total Value
$609.05K
Shares Held After
8,449
% of Holdings
54.4%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
12,479
Price
$59.50
Total Value
$742.50K
Shares Held After
18,521
% of Holdings
40.3%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
21,515
Price
$60.49
Total Value
$1.30M
Shares Held After
6,000
% of Holdings
78.2%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
31,694
Price
$59.88
Total Value
$1.90M
Shares Held After
27,515
% of Holdings
53.5%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
21,791
Price
$58.81
Total Value
$1.28M
Shares Held After
59,209
% of Holdings
26.9%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
200
Price
$10.17
Total Value
$2.03K
Shares Held After
21,706
% of Holdings
0.9%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Title: Chief Technology and Manufacturing Officer
Shares
479
Price
$2.54
Total Value
$1.21K
Shares Held After
525,503
% of Holdings
0.1%
Entera Bio Ltd. (ENTX)
Germano Geno J — Director
Shares
20,000
Price
$1.30
Total Value
$26.00K
Shares Held After
40,000
% of Holdings
50.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$26.84
Total Value
$58.27K
Shares Held After
82,489
% of Holdings
2.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Caudill Cortney — SVP, CHIEF OPERATING OFFICER
Shares
2,100
Price
$68.25
Total Value
$143.33K
Shares Held After
14,366
% of Holdings
12.8%
Showing 401–450 of 3377 transactions (page 9 of 68)